4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-25-017475
Options or other derivatives
- CEO, CFO acquired 9,179,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Finley John David CEO, CFO | 2025-10-06 | Grant or award · Restricted Stock Units | +9,179,400 | 9,179,400 | D | ||
Loading xslF345X05/ownership.xml…